Comparison of interventions for intermediate to high-risk pulmonary embolism: A network meta-analysis.
暂无分享,去创建一个
T. Kuno | Tomohiro Fujisaki | Shunsuke Aoi | M. Iwagami | Eric A. Secemsky | J. Wiley | M. So | D. Steiger | Atsuyuki Watanabe | Y. Ishisaka
[1] J. Giri,et al. Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial. , 2022, JAMA cardiology.
[2] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[3] C. Weng,et al. Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study , 2021, PloS one.
[4] B. Murray,et al. Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism , 2020, Journal of Thrombosis and Thrombolysis.
[5] V. Tapson,et al. How I Do It: The PERT Concept: A Step-by-Step Approach to Managing PE. , 2020, Chest.
[6] M. Pelletier,et al. National Outcomes of Surgical Embolectomy for Acute Pulmonary Embolism. , 2020, The Annals of thoracic surgery.
[7] C. Toma,et al. Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism , 2020, Pulmonary circulation.
[8] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .
[9] G. Merli,et al. First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation , 2019, Hospital practice.
[10] C. Hennemeyer,et al. Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism. , 2019, The American journal of medicine.
[11] N. Ozdemir,et al. Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis. , 2017, Current vascular pharmacology.
[12] Salma I. Patel,et al. Catheter-Directed Treatment of Pulmonary Embolism: A Systematic Review and Meta-Analysis of Modern Literature , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[13] L. Dell’Italia,et al. Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses. , 2016, International journal of cardiology.
[14] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[15] C. Grines,et al. Utilization of catheter‐directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter‐directed thrombolysis , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[16] L. Cohn,et al. Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients. , 2015, The Annals of thoracic surgery.
[17] Gerta Rücker,et al. Ranking treatments in frequentist network meta-analysis works without resampling methods , 2015, BMC Medical Research Methodology.
[18] M. Salehi,et al. Surgical embolectomy versus thrombolytic therapy in the management of acute massive pulmonary embolism: Short and long-term prognosis. , 2015, Heart & lung : the journal of critical care.
[19] J. Giri,et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. , 2014, JAMA.
[20] J. Hernández,et al. Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin , 2009, Journal of Thrombosis and Thrombolysis.
[21] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.